First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer
Not yet recruiting · NCT07756281 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pancreatic Acinar Carcinoma, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 1 | 2026-08-10 | NCT07756281 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Revolution Medicines, Inc. | 18 |
| Synnovation Therapeutics, Inc. | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||